Feedback / Questions
IN10028 - InxMed
FAK Inhibitor in Patients With Advanced Solid Tumors
(clinicaltrials.gov)
-
May 20, 2026 -
P1 | N=75 | Not yet recruiting | Sponsor: InxMed (Shanghai) Co., Ltd.
Monotherapy • New P1 trial
•
Oncology • Solid Tumor
http://clinicaltrials.gov/ct2/show/NCT07596381
May 20, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next